Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease

Saved in:
Bibliographic Details
Published in:Hematological oncology 2017-06, Vol.35 (S2), p.344-344
Main Authors: Salas, Q.Q., Domingo Domenech, E., Mercadal, S., Oliveira, A., Aguilera, C., De la Banda, E., Climent, F., Lucas, A., Garcia, N., Baca, C., Fernandez de Sevilla, A., Sureda, A., González Barca, E.
Format: Article
Language:English
Subjects:
B-cell lymphoma
Lymphocytes B
Lymphoma
Patients
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2439_92